Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Clinical trial NCT07325292 · RECRUITING

Trial details

NCT number: NCT07325292
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2026-01-14
Primary completion: 2027-07-15
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.